Gatti et al. has shown that inflammation reflected in high plasma CRP and PCT concentrations may down-regulate the metabolism of voriconazole in patients with COVID-19-associated aspergillosis, resulting in potentially toxic voriconazole concentrations [43]. This evidence concerns the gene CRP and COVID-19.